EANS-News: Oxygen Biotherapeutics Inc. / Oxycyte® PFCE Decreases Mortality From Decompression Sickness in Preclinical Study
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information/Research & Development/Biotechnology Durham, NC (euro adhoc) - Oxycyte® PFCE Decreases Mortality From Decompression Sickness in Preclinical Study DURHAM, NC, June ...